Search

everythinglearnresearchcommunity

for

Search:↓

T cell subsets are crucial in kidney cancer, and a new model predicts patient outcomes using key genes.

Ion channels play a key role in ovarian cancer growth and treatment resistance.

Increased ODC activity leads to skin tumors by recruiting stem cells, not by toxic byproducts.

External factors can cause skin cancer cells that usually don't spread to grow and form tumors in mice.

Antiviral medication valganciclovir may improve skin and hair in Trichodysplasia Spinulosa patients.

Genomic profiling for myeloid cancers can find important inherited mutations, but it's challenging when these mutations aren't related to the patient's symptoms.

Cialis and Finasteride could be repurposed to treat aggressive melanoma.

Certain changes in the VEGF gene can increase or decrease the risk of polycystic ovary syndrome.

The research suggests new treatments for skin cancer could target specific cell growth pathways.

S100A4 promotes aggressive ovarian cancer and is a potential treatment target.

A boy with severe immune deficiency and Epstein-Barr virus died from high-grade B-cell lymphoma.

Virus infection risk is linked to heat tolerance and size, but decreases with high humidity and mutation rates.

UV radiation causes skin cancer, but sunscreens and certain drugs can help prevent it.

REV7 is crucial for genome stability and cancer treatment, making it a potential target for therapy.

Cancer can hijack the body's cell repair system to promote tumor growth, and targeting this process may improve cancer treatments.

Rapid virilization should be checked for possible ovarian or adrenal cancer.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.

ODC1 gene mutations cause a neurodevelopmental disorder with large head size, hair loss, and facial abnormalities.

K10 may not prevent tumors as previously thought and might increase benign tumor risk.

Blocking mTORC1 reduces skin tumor growth in mice.

New hair regrowth model introduced, imiquimod kills skin cancer cells, T-cadherin loss makes skin cancer more invasive, no strong link between PTCH1 gene and skin cancer after transplant, and male teens more likely to have hereditary hair loss.

The virus linked to a rare disease was found in a patient's blood and urine before skin symptoms appeared.

Inhibiting ornithine decarboxylase may help prevent certain skin cancers.

Mitochondrial genes help predict breast cancer outcomes and spread.

A woman with high testosterone and an adrenal nodule had an ovarian tumor causing her symptoms, which improved after the tumor was removed.

Early sunburn treatment with certain inhibitors may reduce skin cancer risk.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

SOX4 is crucial for the development of melanoma.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

MYC protooncogenes may be important for hair growth, but more research is needed.